Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Michael K. Yoon, MD
Healthcare Professional Ophthalmologist
Massachusetts Eye and Ear
243 Charles Street
Boston, Massachusetts, United States
Dr. Michael Yoon is a member of the Massachusetts Eye and Ear Ophthalmic Plastic Surgery Service, as well as the Center for Thyroid Eye Disease and Orbital Surgery. He treats patients with orbit, eyelid, and tear drainage system dysfunctions. He specializes in orbital tumors and inflammations, traumatic lacerations and fractures, and reconstructive and cosmetic eyelid surgery.
Dr. Yoon graduated magna cum laude from an accelerated medical degree program at Albany Medical College and Union College. He completed his ophthalmology residency training at Tufts-New England Medical Center and received the ophthalmic knowledge assessment program achievement award. He went on to complete fellowship training in neuro-ophthalmology, orbital surgery, and ophthalmic plastic and reconstructive surgery at the University of California, San Francisco, Medical Center.
While Dr. Yoon’s clinical practice and teaching constitute the majority of his work at Massachusetts Eye and Ear, he is also a productive clinical researcher. He is especially interested in studying ways to improve the diagnosis and treatment of orbital diseases, including that involve growths in the eye socket. He also investigates thyroid-related eye disease, which can cause changes in the eye socket that may lead to impaired vision, including double vision or vision loss.
Representative Publications:
Autologous Dermal Grafts as Posterior Lamellar Spacers in the Management of Lower Eyelid Retraction
A National Survey of Practice Patterns: Temporal Artery Biopsy
Secondary Tarsoconjunctival Graft: A Modification to the Cutler-Beard Procedure
Current Trends in the Management of Thyroid Eye Disease
Central Retinal Vein Occlusion Resolving After Orbital Decompression in Thyroid Eye Disease
Related Content
-
Clinical Implications of Immunoglobulin G4 to Graves’ OphthalmopathyBackground: This study aimed to explore...
-
Patients’ Expectations for the Functional and Psychosocial Outcomes of Orbital Decompression Surgery for Thyro...Patients with appearance-altering condit...
-
Robert B. Penne, MD, FACSRobert B. Penne, MD is Chief of the Ocul...
-
Alon Kahana, MD, PhDDr. Alon Kahana is the President of Kaha...
-
Efficacy and Safety of Mycophenolate Mofetil in Patients With Active Moderate-to-Severe Graves’ OrbitopathyContext: Graves' orbitopathy (GO) is a ...
-
Horizon Pharma plc Announces Phase 3 Confirmatory Trial Evaluating Teprotumumab (OPTIC) for the Treatment of Active ...Horizon Pharma plc today announced topli...
-
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves’ OrbitopathyImportance: Graves orbitopathy (GO) res...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.